Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Medinotec (MDNC) EBITDA (2022 - 2025)

Historic EBITDA for Medinotec (MDNC) over the last 4 years, with Q4 2025 value amounting to $662887.0.

  • Medinotec's EBITDA rose 12386.74% to $662887.0 in Q4 2025 from the same period last year, while for Nov 2025 it was $2.6 million, marking a year-over-year increase of 24178.83%. This contributed to the annual value of $2.1 million for FY2025, which is 64094.74% up from last year.
  • According to the latest figures from Q4 2025, Medinotec's EBITDA is $662887.0, which was up 12386.74% from $359538.0 recorded in Q3 2025.
  • Over the past 5 years, Medinotec's EBITDA peaked at $1.4 million during Q1 2025, and registered a low of -$491911.0 during Q4 2023.
  • Moreover, its 4-year median value for EBITDA was $74971.5 (2023), whereas its average is $152266.8.
  • Per our database at Business Quant, Medinotec's EBITDA crashed by 90780.78% in 2023 and then surged by 147193.04% in 2025.
  • Over the past 4 years, Medinotec's EBITDA (Quarter) stood at -$48810.0 in 2022, then plummeted by 907.81% to -$491911.0 in 2023, then surged by 160.2% to $296107.0 in 2024, then skyrocketed by 123.87% to $662887.0 in 2025.
  • Its last three reported values are $662887.0 in Q4 2025, $359538.0 for Q3 2025, and $97993.0 during Q2 2025.